Medicine and Dentistry
Acute Coronary Syndrome
21%
Adolescent
22%
Adverse Event
8%
All Cause Mortality
19%
Antidepressant
17%
Bipolar Disorder
100%
Bipolar I Disorder
14%
Cardiovascular Disease
26%
Cardiovascular Mortality
7%
Cardiovascular Risk
15%
Cardiovascular System
18%
Clinical Trial
8%
Cohort Analysis
46%
Depression
11%
Diagnosis
10%
Diagnosis of Schizophrenia
11%
Diseases
36%
Drug Therapy
19%
Electroconvulsive Therapy
10%
Electromagnetic Field
7%
Epileptic Seizure
12%
Gut Microbiota
9%
Hazard Ratio
10%
Heart Failure
7%
ICD-10
15%
Isotopes of Calcium
22%
Lifespan
7%
Major Depressive Episode
40%
Mental Disorder
8%
Mental Health
11%
Meta-Analysis
14%
Montgomery-Åsberg Depression Rating Scale
8%
Mood Disorder
8%
Mortality Rate
17%
Multiple Chronic Conditions
14%
Myocardial Infarction
8%
Observational Study
14%
Odds Ratio
11%
Pediatrics
35%
Physical Disease
8%
Population
31%
Psychoactive Drug
11%
Psychogenic Non-Epileptic Seizures
21%
Severe Mental Illness
31%
Somatics
22%
Standardized Mortality Ratio
16%
Symptom
21%
Systematic Review
28%
Treatment Resistant Depression
17%
Typical Antipsychotic
17%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcysteine
14%
Acute Coronary Syndrome
21%
Acute Myeloid Leukemia
7%
Adverse Event
10%
All Cause Mortality
26%
Alzheimer's Disease
14%
Antidepressant
11%
Antipsychotic
46%
Autonomic Neuropathy
7%
Benzodiazepine
12%
Bipolar Depression
14%
Bipolar Disorder
61%
Cardiovascular Disease
24%
Cardiovascular Mortality
7%
Cardiovascular Risk
8%
Cardiovascular System Cancer
7%
Case-Control Study
7%
Citalopram
7%
Clinical Trial
8%
Clozapine
25%
Cohort Study
38%
Coronary Artery Calcification
7%
Disease
31%
End Stage Renal Disease
7%
Galantamine
7%
Heart Infarction
8%
Hodgkin Disease
7%
Major Depression
8%
Mortality Rate
25%
Multiple Chronic Conditions
7%
Myelodysplastic Syndrome
7%
Negative Syndrome
14%
Nonhodgkin Lymphoma
7%
Observational Study
14%
Onset Age
7%
Pharmacotherapy
10%
Physical Disease
7%
Placebo
24%
Placebo-Controlled Study
7%
Polypharmacy
15%
Positive Syndrome
11%
Psilocybin
7%
Psychotropic Agent
32%
Quetiapine
9%
Rivastigmine
7%
Schizophrenia Spectrum Disorder
14%
Sertindole
14%
Standardized Mortality Ratio
8%
Typical Antipsychotic
51%
Vitamin D
7%
Keyphrases
Acute Coronary Syndrome
7%
Antipsychotic Effect
7%
Auditory Hallucinations
7%
Big Data
7%
Bipolar Disorder
50%
Cardiovascular and Cerebrovascular Diseases
7%
Cardiovascular Autonomic Neuropathy
7%
Cardiovascular Disease
10%
Clinical Overview
7%
Comorbidity
7%
Consultation-liaison Psychiatry
7%
Coronary Artery Calcium Score
7%
Depression during Pregnancy
7%
Diagnostic Change
7%
Diagnostic Stability
7%
Drug Attitude Inventory
7%
Drugs in Pregnancy
7%
Early-onset Schizophrenia
7%
Expert Management
7%
Hodgkin Lymphoma
7%
Inconvenience
7%
Increased Mortality
8%
International Classification of Diseases-11
7%
Life Expectancy
7%
Lithium
14%
MADRS
7%
Maintenance Treatment
7%
Major Depressive Disorder
7%
Mortality Rate
10%
National Cohort Study
14%
Negative Syndrome
8%
Patient Contact
7%
Patients with Schizophrenia
21%
Pediatric Onset
7%
Psilocybin
7%
Randomized Placebo-controlled Trial
7%
Regret
7%
Risk Factors for Cardiovascular Diseases
7%
Risk Factors Prevention
7%
Schizophrenia
11%
Schizophrenia Symptoms
14%
Schizophrenic
7%
Semantic Search System
7%
Severe Mental Illness
10%
Somatic Symptoms
8%
Standardized Mortality Ratio
7%
Treatment-resistant
7%
Treatment-resistant Depression
10%
Ultraviolet B Radiation
7%
Unnatural Deaths
7%